2-[1H]-quinolone and 2-[1H]-quinoxalone inhibitors of factor Xa

   
   

Novel compounds of general formula I: ##STR1## including their pharmaceutically acceptable isomers, salts, hydrates, solvates and prodrug derivative having activity against mammalian factor Xa is described. Compositions containing such compounds are also described. The compounds and compositions are useful in vitro or in vivo for preventing or treating conditions in mammals characterized by undesired thrombosis.

Compuestos de la novela del fórmula general I: ## del ## STR1 incluyendo sus isómeros farmacéutico aceptables, se describe las sales, los hidratos, los solvates y el derivado del prodrug que tiene actividad contra el factor mamífero XA. Las composiciones que contienen tales compuestos también se describen. Los compuestos y las composiciones son ines vitro o ines vivo útil para las condiciones de prevención o que tratan en los mamíferos caracterizados por trombosis indeseada.

 
Web www.patentalert.com

< Distributed radio system with multiple transceivers for simulcasting and selective processing of received signals

< POLYHYDROXYALKANOATE CONTAINING UNIT WITH THIENYL STRUCTURE IN THE SIDE CHAIN, PROCESS FOR ITS PRODUCTION, CHARGE CONTROL AGENT, TONER BINDER AND TONER WHICH CONTAIN THIS POLYHYDROXYALKANOATE, AND IMAGE-FORMING METHOD AND IMAGE-FORMING APPARATUS WHICH MAKE USE OF THE TONER

> Hollow microspheres with controlled fragility for medical use

> Soluble zalpha11 cytokine receptors

~ 00125